Navigation Links
Metal-on-Metal Hip Implants: Bernstein Liebhard LLP Comments on New Study Finding that Tissue Damage Precedes Pain in Metal-on-Metal Hip Replacement Patients
Date:5/18/2013

New York, New York (PRWEB) May 18, 2013

As metal-on-metal hip implant lawsuits continue to mount in courts throughout the country, Bernstein Liebhard LLP notes that a new study has found that metal-on-metal hip replacement patients often suffer tissue damage before they experience any pain from a hip. During the study, which according to Science Daily will appear in the Journal of Bone & Joint Surgery, 69 metal-on-metal hip replacement recipients underwent MRI screens of their hips. The researchers found tissue damage in roughly the same number of asymptomatic and symptomatic patients. The authors of the study concluded that symptoms alone are not a sufficient means of monitoring metal-on-metal hip implant patients.*

“We agree with the authors of the study that patients fitted with metal-on-metal hip replacements need careful screening, possibly including blood and imaging testing, to ensure their devices are functioning properly,” says Bernstein Liebhard LLP, a nationwide law firm representing the victims of defective drugs and medical devices. The Firm continues to offer free legal evaluations to alleged victims of metal-on-metal hip replacement devices.

Metal-on-Metal Hip Replacement Lawsuits
The U.S. Food & Drug Administration (FDA) is currently evaluating the safety of metal-on-metal hip implants, which are the subject of a growing number of lawsuits that allege the devices can shed dangerous amounts of metal ions, resulting in metallosis, adverse local tissue reactions, and early failure of the device. In January, the FDA proposed a new rule that would make all-metal hips ineligible for 510(k) approvals, which allow a device to come to market without human testing if a manufacturer can demonstrate that it is similar in design to a previou
'/>"/>

Source: PRWeb
Copyright©2012 Vocus, Inc.
All rights reserved

Page: 1 2 3 4

Related medicine news :

1. DePuy Announces It Will Stop Selling Metal-On-Metal Hip Implants, Notes Rottenstein Law Group LLP
2. DePuy Pinnacle Hip Implant Lawsuit News: Bernstein Liebhard LLP Comments on Johnson & Johnson Decision to Stop Metal-on-Metal Hip Sales
3. Metal-on-Metal Hip Implants: Bernstein Liebhard LLP Applauds American Association for Justice Position on Metal-on-Metal Hip Replacement Regulation
4. MRI may predict adverse tissue reaction in metal-on-metal hip replacement patients
5. Metal-on-Metal Hip Implants: Bernstein Liebhard LLP Comments on New Study Finding Increased Metal Ion Levels May Predict Problems with Metal-on-Metal Hip Replacements
6. FDA Says Metal-on-Metal Hip Replacements Can Cause Soft-Tissue Damage, Rottenstein Law Group Reports
7. New Metal-on-Metal Hip Implant Study Emphasizes Importance of Patients’ Symptoms in Evaluating the Need for Hip Replacement Revisions, Bernstein Liebhard LLP Reports
8. Few Patients Should Get Metal-on-Metal Hip Implants, FDA Panel Says
9. FDA Probing Safety of Metal-on-Metal Hip Implants
10. Stryker Hip Lawsuit News: Bernstein Liebhard LLP Reports on Recent Case Management Conference in New Jersey Stryker Hip Recall Litigation
11. Wright Conserve Hip Replacement Lawsuits Move Forward, as Bernstein Liebhard LLP Notes Issuance of Amended Discovery Plan in Federal Wright Hip Litigation
Post Your Comments:
*Name:
*Comment:
*Email:
(Date:4/28/2015)... 28, 2015 The popular all-natural supplement ... for their newly launched L-Style Revolution Program™, and collectively ... counting in just two short months. The customized ... exercise plan for men and women of all health ... loss and weight maintenance goals faster than traditional methods. ...
(Date:4/28/2015)... MSA Executive Search , an INTEGRATED ... that it has been retained to lead a nationwide ... for The Queen's Health Systems (QHS) located in ... & CEO Arthur A. Ushijima, the Executive Vice President ... the Queen’s Medical Center Punchbowl and West O’ahu sites, ...
(Date:4/28/2015)... PA (PRWEB) April 28, 2015 An ... Blair A. Jobe, MD, FACS , has launched ... esophageal tissue with extracellular matrix (ECM) can help patients ... form of esophageal cancer. , ECM is a complex ... cell attachment and migration and signals that guide cell ...
(Date:4/28/2015)... New and more complex medicines ... manufacturers, payers, pharmacists and patients. Now Specialty Pharmacy ... partnering with the National Association of Specialty Pharmacy ... to this developing field to better equip pharmacy ... , “This partnership creates a powerful platform for ...
(Date:4/28/2015)... Chicago, IL (PRWEB) April 28, 2015 ... enhance its research and healthcare services programs, the ... Orlando, Ph.D. Orlando comes to MDA from Fidelity ... oversaw funding of research projects in neurodegenerative diseases ... scientific conferences. Prior to her time at Fidelity, ...
Breaking Medicine News(10 mins):Health News:Sports Nutrition Supplement Brand, Liporidex, Is Making History With Its New L-Style Revolution Diet & Exercise Program Reaching Over 10,000 Pounds Lost In Two Months 2Health News:Sports Nutrition Supplement Brand, Liporidex, Is Making History With Its New L-Style Revolution Diet & Exercise Program Reaching Over 10,000 Pounds Lost In Two Months 3Health News:The Queen’s Health Systems Retains MSA Executive Search to Recruit Executive Vice President & Chief Operating Officer 2Health News:Allegheny Health Network Launches First U.S. Clinical Trial of Extracellular Matrix as Replacement for Pre-Cancerous Tissue 2Health News:Allegheny Health Network Launches First U.S. Clinical Trial of Extracellular Matrix as Replacement for Pre-Cancerous Tissue 3Health News:Specialty Pharmacy Times Partners with National Association of Specialty Pharmacy to Improve Care for Patients 2Health News:Specialty Pharmacy Times Partners with National Association of Specialty Pharmacy to Improve Care for Patients 3Health News:Specialty Pharmacy Times Partners with National Association of Specialty Pharmacy to Improve Care for Patients 4Health News:MDA Adds Neurological Disease Expert to Research Team 2Health News:MDA Adds Neurological Disease Expert to Research Team 3
... , , , REDMOND, ... meeting that seeks solely to personally enlighten and transform the people ... annual meeting under the vision of Chairman and CEO Dwayne ... memory care communities, Aegis Living is in the business of taking ...
... , WASHINGTON , Jan. ... announced that it has filed a motion for immediate relief ... Georgia from the imminent and serious threat of ... late yesterday, seeks appointment of a monitor who will set ...
... online resources, coping tips , FRIDAY, Jan. 29 (HealthDay ... for 75 percent of adult cancer patients, according to ... , Breakthrough cancer pain refers to sudden, temporary flares ... is taking pain medication. , "We,re not talking about ...
... when caught early. But in a third of cases, ... when cure is much less likely. , Quicker identification ... mathematical model developed by researchers at the Ohio State ... Richard J. Solove Research Institute., The model uses information ...
... Association of Physicists in Medicine (AAPM) has issued a statement ... New York Times yesterday and earlier in the week that ... last decade involving people undergoing radiation therapy. While it ... the statement acknowledges their gravity. It reads in part: "The ...
... 2010 Investigators from the International Center for Biomedicine ... Center for Bioinformatics of the Universidad de Talca, have ... astemizole, may be suitable for use as PET (positron ... detection of Alzheimer,s Disease. The study is published in ...
Cached Medicine News:Health News:Aegis Living's CEO Transforms Business As Usual One Employee At a Time 2Health News:Aegis Living's CEO Transforms Business As Usual One Employee At a Time 3Health News:Justice Department Files for Immediate Relief Regarding Conditions in Georgia's Hospitals 2Health News:Justice Department Files for Immediate Relief Regarding Conditions in Georgia's Hospitals 3Health News:Justice Department Files for Immediate Relief Regarding Conditions in Georgia's Hospitals 4Health News:Three-Fourths of Cancer Patients Have Severe Flares of Pain 2Health News:Three-Fourths of Cancer Patients Have Severe Flares of Pain 3Health News:Curing more cervical cancer cases may be in the math 2Health News:AAPM statement on quality radiation therapy 2Health News:Promising new neuroimaging techniques for early detection of Alzheimer's disease 2
(Date:4/28/2015)...  Olympus, a precision technology leader in designing and ... other core businesses, announced today the opening of its ... MN. The new medical device research & ... company for continued long-term growth in the surgical sector. ... on April 27 and was attended by Mark ...
(Date:4/28/2015)... 28, 2015  Securities lawyers at Dunnam & ... ANGO ). Concerned ANGO investors who purchased between ... to contact securities attorney Hamilton Lindley by clicking ... 9, 2015, a quarterly loss of $4.3 million and ... year to a range of $356 million to $360 ...
(Date:4/28/2015)... Oramed Pharmaceuticals Inc. (NASDAQ: ORMP ) ( http://www.oramed.com ... I am very excited to announce that we are on ... for oral insulin (ORMD-0801) and the treatment of type 2 ... coming weeks. This clinical trial will be our largest and most ... the company, literally putting us in a different place. ...
Breaking Medicine Technology:Olympus Opens New Surgical Innovation Center, Positioning Company for Long-term Growth 2Olympus Opens New Surgical Innovation Center, Positioning Company for Long-term Growth 3Olympus Opens New Surgical Innovation Center, Positioning Company for Long-term Growth 4Oramed Pharmaceuticals Inc. Issues Phase IIb Study Update Letter 2Oramed Pharmaceuticals Inc. Issues Phase IIb Study Update Letter 3
... KineMed Inc., a,pathway-based drug discovery and development ... of an investigational agent,to regenerate nerve cells in ... cognition and mood. The agent, part of a ... a behavioral test in a,preclinical model. The findings ...
... am ET, BEDMINSTER, N.J., Oct. 11 ... top-line results from,the company,s Phase 3 study of ... 83 patients with short bowel,syndrome (SBS) received either ... dose (0.10 mg/kg/day) or placebo. The,clinical efficacy endpoint ...
Cached Medicine Technology:KineMed Presents Preclinical Data for Investigational Agent Demonstrating Neurogenesis and Confirming Improvements in Behavioral Model 2KineMed Presents Preclinical Data for Investigational Agent Demonstrating Neurogenesis and Confirming Improvements in Behavioral Model 3Clinical Benefits Demonstrated with Low-Dose GATTEX(TM) in Phase 3 Short Bowel Syndrome Study 2Clinical Benefits Demonstrated with Low-Dose GATTEX(TM) in Phase 3 Short Bowel Syndrome Study 3Clinical Benefits Demonstrated with Low-Dose GATTEX(TM) in Phase 3 Short Bowel Syndrome Study 4Clinical Benefits Demonstrated with Low-Dose GATTEX(TM) in Phase 3 Short Bowel Syndrome Study 5Clinical Benefits Demonstrated with Low-Dose GATTEX(TM) in Phase 3 Short Bowel Syndrome Study 6Clinical Benefits Demonstrated with Low-Dose GATTEX(TM) in Phase 3 Short Bowel Syndrome Study 7
... continue the outstanding worldwide ... microscopes in medical and ... UIS infinity-corrected optics. The ... performance and even greater ...
... Coolscope operates with a simple click ... display. Direct the mouse cursor to ... image of the slide and the ... intuitive Graphic User Interface (GUI) enables ...
... Eclipse TS100 is an innovative ... This high quality tool complements ... and increased stability - Nikon ... vibration resistant design that greatly ...
Carbide drill bits, cutters, side cutting. Available in various sizes....
Medicine Products: